ADU-S100

null · Chinook Therapeutics, Inc. (formerly Aduro)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADU-S100, covering 2022-01-03 to 2022-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer [Phase 2]